These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7589279)

  • 21. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
    Duru F; Ertem U; Taçyildiz N; Kirazli S
    J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
    Frankel AE; Powell BL; Hall PD; Case LD; Kreitman RJ
    Clin Cancer Res; 2002 May; 8(5):1004-13. PubMed ID: 12006512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.
    Archimbaud E; Fenaux P; Reiffers J; Cordonnier C; Leblond V; Travade P; Troussard X; Tilly H; Auzanneau G; Marie JP
    Leukemia; 1993 Mar; 7(3):372-7. PubMed ID: 8445942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
    Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
    Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
    Schönbohn H; Schuler M; Kolbe K; Peschel C; Huber C; Bemb W; Aulitzky WE
    Ann Hematol; 1995 Oct; 71(4):161-8. PubMed ID: 7578521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro.
    Bruserud O; Nesthus I; Bühring HJ; Pawelec G
    Leuk Res; 1995 Jan; 19(1):15-22. PubMed ID: 7530789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis.
    Berner R; Niemeyer CM; Leititis JU; Funke A; Schwab C; Rau U; Richter K; Tawfeek MS; Clad A; Brandis M
    Pediatr Res; 1998 Oct; 44(4):469-77. PubMed ID: 9773833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.
    Logan TF; Gooding W; Kirkwood JM; Shadduck RK
    Exp Hematol; 1996 Jan; 24(1):49-53. PubMed ID: 8536792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of stem cell factor in the in vitro growth of blast clonogenic cells from patients with acute myeloblastic leukemia.
    Murohashi I; Endoh K; Feng M; Yoshida K; Hirota H; Yoshida S; Jinnai I; Bessho M; Hirashima K
    J Interferon Cytokine Res; 1995 Oct; 15(10):829-35. PubMed ID: 8564703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
    Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
    J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.
    Wagteveld AJ; Esselink MT; Limburg P; Halie MR; Vellenga E
    Leukemia; 1992 Oct; 6(10):1020-4. PubMed ID: 1405754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.
    Steffen M; Budde-Steffen C; Gabrilove JL; Moore MA
    Leukemia; 1992 Jul; 6(7):634-41. PubMed ID: 1378161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors.
    Backx B; Broeders L; Bot FJ; Löwenberg B
    Leukemia; 1991 Jan; 5(1):66-70. PubMed ID: 1705638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.